General Announcement::Announcement by TMC Life Sciences Bhd, 3Q2021 results for the period ended 31 Mar 2021

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$225M4.8%N220718 - SGXF90488481 - YRYB
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
25-May-2021 18:15:35
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Bhd, 3Q2021 results for the period ended 31 Mar 2021
Announcement Reference
SG210525OTHRU6QD
Submitted By (Co./ Ind. Name)
Lim Hoi Leong
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please see attached.

Attachments

TMCLS_Announcement_Q32021-Final.pdf
TMCLS_Announcement_Q32020-Final.pdf
Total size =611K